Renal cell cancer: causes, prognosis, management and treatments
Jane Boxall Research nurse in medical oncology (renal cell cancer and metastatic melanoma), Mount Vernon Hospital, Middlesex
Paul Nathan Consultant medical oncologist, Department of Medical Oncology, Mount Vernon Hospital, Middlesex
Most patients who develop renal cell or kidney cancer can be treated with a radical nephrectomy. However, for those who present with metastatic disease, the therapeutic options are limited to interferon and interleukin-2. Response rates to these cytokine treatments range from 10 to 20 per cent but the drugs carry substantial toxicity. This article discusses the new biological agents currently in development for the treatment of kidney cancer.
Cancer Nursing Practice.
5, 3, 29-33.
doi: 10.7748/cnp2006.04.5.3.29.c181
Want to read more?
Already have access? Log in
or
3-month trial offer for £5.25/month
Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
- Unlimited access to all 10 RCNi Journals
- RCNi Learning featuring over 175 modules to easily earn CPD time
- NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
- Personalised newsletters tailored to your interests
- A customisable dashboard with over 200 topics
Subscribe
Alternatively, you can purchase access to this article for the next seven days.
Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
